132 related articles for article (PubMed ID: 149492)
1. The immunopharmacologic and anti-inflammatory properties of RMI 9563 with special reference to its effect on the complement system.
Megel H; Raychaudhuri A; Bayer M; Beaver TH
Agents Actions; 1978 Apr; 8(3):218-28. PubMed ID: 149492
[TBL] [Abstract][Full Text] [Related]
2. Tilorone: its selective effects on humoral and cell-mediated immunity.
Megel H; Raychaudhuri A; Goldstein S; Kinsolving CR; Shemano I; Michael JG
Proc Soc Exp Biol Med; 1974 Feb; 145(2):513-8. PubMed ID: 4360642
[No Abstract] [Full Text] [Related]
3. The anti-inflammatory actions of tilorone hydrochloride.
Megel H; Raychaudhuri A; Shemano I; Beaver TH; Thomas LL
Proc Soc Exp Biol Med; 1975 May; 149(1):89-93. PubMed ID: 124872
[TBL] [Abstract][Full Text] [Related]
4. The activity of an anti-allergic compound, proxicromil, on models of immunity and inflammation.
Keogh RW; Bundick RV; Cunnington PG; Jenkins SN; Blackham A; Orr TS
Agents Actions; 1981 Jul; 11(4):361-72. PubMed ID: 6456651
[TBL] [Abstract][Full Text] [Related]
5. The interaction of tilorone and RMI 9563DA with the complement system.
Doherty NS
Int J Immunopharmacol; 1982; 4(1):67-72. PubMed ID: 7085140
[TBL] [Abstract][Full Text] [Related]
6. [Effect of KP-136 on allergic paw edema in the rat].
Hiyama Y; Kuriyama K
Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):83-90. PubMed ID: 2141318
[TBL] [Abstract][Full Text] [Related]
7. P-selectin requirement for neutrophil accumulation and injury in the direct passive Arthus reaction.
Santos LL; Huang XR; Berndt MC; Holdsworth SR
Clin Exp Immunol; 1998 May; 112(2):281-6. PubMed ID: 9649192
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
Tomioka K; Yamada T; Mase T; Murase K
Pharmacology; 1989; 39(1):28-38. PubMed ID: 2531424
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anti-inflammatory compounds in the carrageenan induced paw edema model and the reversed passive Arthus model utilizing the same animal.
Reiter MJ; Schwartzmiller DH; Swingle KF; Moore GG; Goldlust MB; Heghinian K; DeVore DP; Choy B; Weppner WA
Life Sci; 1985 Apr; 36(14):1339-46. PubMed ID: 3157038
[TBL] [Abstract][Full Text] [Related]
10. Effect of oleanolic acid on complement in adjuvant- and carrageenan-induced inflammation in rats.
Kapil A; Sharma S
J Pharm Pharmacol; 1995 Jul; 47(7):585-7. PubMed ID: 8568626
[TBL] [Abstract][Full Text] [Related]
11. Role of fumaropimaric acid in guinea pig complement dependent and non-complement dependent biologic reactions. I. Inhibition of Forssman, reversed passive arthus, and PCA reactions by fumaropimaric acid.
Glovsky MM; Ward PA; Becker EL; Halbrook NJ
J Immunol; 1969 Jan; 102(1):1-14. PubMed ID: 4237108
[No Abstract] [Full Text] [Related]
12. Locus ceruleus and immunity. II. Suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus.
Jovanova-Nesić K; Nikolić V; Janković BD
Int J Neurosci; 1993 Feb; 68(3-4):289-94. PubMed ID: 8063534
[TBL] [Abstract][Full Text] [Related]
13. Immunopharmacologic properties of 1,6-bis[2-(diethylamino)ethoxy]xanthen-9-one dihydrochloride (Wy-15297).
Rosenthale ME; Santilli AA; Scotese AC; Bell SC; Rubin BA
J Immunopharmacol; 1980; 2(2):257-77. PubMed ID: 6821553
[TBL] [Abstract][Full Text] [Related]
14. [Effect of carrageenan on the course of experimental allergic encephalomyelitis in the rat].
Vymazal J; Krásenská-Dlabacová J; Miler I; Malbohan I
Cesk Neurol Neurochir; 1974 Nov; 37(6):345-8. PubMed ID: 4426099
[No Abstract] [Full Text] [Related]
15. Complement-inhibiting and anti-inflammatory properties of chlorazole fast pink 2BL.
Doherty NS
Clin Exp Immunol; 1981 Feb; 43(2):260-9. PubMed ID: 7273480
[TBL] [Abstract][Full Text] [Related]
16. The Arthus reaction in rodents: species-specific requirement of complement.
Szalai AJ; Digerness SB; Agrawal A; Kearney JF; Bucy RP; Niwas S; Kilpatrick JM; Babu YS; Volanakis JE
J Immunol; 2000 Jan; 164(1):463-8. PubMed ID: 10605043
[TBL] [Abstract][Full Text] [Related]
17. Specific inactivation of the fourth complement component. I. In vivo studies.
Jensen JA; Garces MC; Iglesias E
Infect Immun; 1971 Jul; 4(1):12-9. PubMed ID: 4263696
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of two colonies of Wistar rats to inflammation, with particular reference to delayed hypersensitivity.
de Brito FB; Hanahoe TH
Int Arch Allergy Appl Immunol; 1983; 72(2):164-9. PubMed ID: 6223888
[TBL] [Abstract][Full Text] [Related]
19. [Decomplementization by a factor extracted from cobra venom. Effect on several immune reactions of the guinea pig and rat].
Maillard JL; Zarco RM
Ann Inst Pasteur (Paris); 1968 Jun; 114(6):756-74. PubMed ID: 4255485
[No Abstract] [Full Text] [Related]
20. The role of complement in the pathogenesis of experimental allergic encephalomyelitis.
Linington C; Morgan BP; Scolding NJ; Wilkins P; Piddlesden S; Compston DA
Brain; 1989 Aug; 112 ( Pt 4)():895-911. PubMed ID: 2476195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
